Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Titel:
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Auteur:
Neumair, P. Joos, L. Warschkow, R. Dutly, A. Ess, S. Hitz, F. Früh, M. Brutsche, M. Baty, F. Krähenbühl, S. Cerny, T. Joerger, M.